Pages that link to "Q41131436"

The following pages link to Evidence for isoproterenol-induced phosphorylation of phosphatase inhibitor-1 in the intact heart (Q41131436):

Displaying 48 items.

• Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome (Q24337593) (← links)
• The relationship between the MMP system, adrenoceptors and phosphoprotein phosphatases (Q27003263) (← links)
• A compartmentalized mathematical model of the β1-adrenergic signaling system in mouse ventricular myocytes (Q28540046) (← links)
• Identification of a novel phosphorylation site in protein phosphatase inhibitor-1 as a negative regulator of cardiac function. (Q33260648) (← links)
• Hormonal control of cardiac ion channels and transporters (Q33710653) (← links)
• Effects of serine/threonine protein phosphatases on ion channels in excitable membranes (Q33807200) (← links)
• Mechanisms of beta-adrenergic stimulation of cardiac Ca2+ channels revealed by discrete-time Markov analysis of slow gating (Q34019850) (← links)
• Type 1 phosphatase, a negative regulator of cardiac function (Q34281889) (← links)
• More severe cellular phenotype in human idiopathic dilated cardiomyopathy compared to ischemic heart disease. (Q34420272) (← links)
• Regulation of protein phosphatase inhibitor-1 by cyclin-dependent kinase 5. (Q34977401) (← links)
• Effects of increased systolic Ca²⁺ and phospholamban phosphorylation during β-adrenergic stimulation on Ca²⁺ transient kinetics in cardiac myocytes. (Q35395918) (← links)
• Ser67-phosphorylated inhibitor 1 is a potent protein phosphatase 1 inhibitor (Q35750011) (← links)
• Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies (Q36593277) (← links)
• Inhibitor-2 prevents protein phosphatase 1-induced cardiac hypertrophy and mortality (Q36995149) (← links)
• Role of PP1 in the regulation of Ca cycling in cardiac physiology and pathophysiology (Q37145537) (← links)
• Role of protein phosphatase-1 inhibitor-1 in cardiac physiology and pathophysiology (Q37276968) (← links)
• Beta-adrenergic stimulation and myocardial function in the failing heart (Q37358922) (← links)
• The role of CaMKII regulation of phospholamban activity in heart disease (Q37555074) (← links)
• Phosphatase-1 inhibitor-1 in physiological and pathological -adrenoceptor signalling (Q37847537) (← links)
• AKAP phosphatase complexes in the heart (Q37874426) (← links)
• SERCA2a: a prime target for modulation of cardiac contractility during heart failure (Q38109648) (← links)
• A pathway and network review on beta-adrenoceptor signaling and beta blockers in cardiac remodeling (Q38173671) (← links)
• Myocardial glycogen dynamics: new perspectives on disease mechanisms. (Q38353514) (← links)
• Role of protein phosphatase inhibitor-1 in cardiac beta adrenergic pathway (Q38820202) (← links)
• Effect of troponin I Ser23/24 phosphorylation on Ca2+-sensitivity in human myocardium depends on the phosphorylation background (Q40012804) (← links)
• 2 Regulation of calcium channels in the heart (Q40493220) (← links)
• Regulation of phospholamban and troponin-I phosphorylation in the intact rat cardiomyocytes by adrenergic and cholinergic stimuli: roles of cyclic nucleotides, calcium, protein kinases and phosphatases and depolarization (Q40950479) (← links)
• Stimulation of protein phosphatases as a mechanism of the muscarinic-receptor-mediated inhibition of cardiac L-type Ca2+ channels (Q41676737) (← links)
• Effects of cantharidin on force of contraction and phosphatase activity in nonfailing and failing human hearts (Q42074948) (← links)
• Inhibition of type 1 protein phosphatase activity by activation of beta-adrenoceptors in ventricular myocardium (Q43946532) (← links)
• Development of a colorimetric and a fluorescence phosphatase-inhibitor assay suitable for drug discovery approaches. (Q44874960) (← links)
• Opposite effect of cAMP signaling in endothelial barriers of different origin (Q45099399) (← links)
• Beta-adrenergic and cholinergic modulation of inward rectifier K+ channel function and phosphorylation in guinea-pig ventricle (Q46305956) (← links)
• Mechanisms of the contractile effects of flosequinoxan (Q46511265) (← links)
• Inhibition of protein phosphatase 1 by inhibitor-2 exacerbates progression of cardiac failure in a model with pressure overload (Q46614182) (← links)
• Expression of calcium regulatory proteins in short-term hibernation and stunning in the in situ porcine heart (Q47864011) (← links)
• Novel mechanism for non‐genomic action of 17β‐oestradiol on kainate‐induced currents in isolated rat CA1 hippocampal neurones (Q48509838) (← links)
• Successful overexpression of wild-type inhibitor-2 of PP1 in cardiovascular cells (Q59360573) (← links)
• Age-Dependent Protein Expression of Serine/Threonine Phosphatases and Their Inhibitors in the Human Cardiac Atrium (Q61807422) (← links)
• Chronic β-adrenergic stimulation reverses depressed Ca handling in mice overexpressing inhibitor-2 of protein phosphatase 1 (Q63330026) (← links)
• Regulation of sarcolemmal Ca2+ pump by endogenous protein phosphatases (Q70458010) (← links)
• beta-adrenergic and cholinergic modulation of the inwardly rectifying K+ current in guinea-pig ventricular myocytes (Q71513443) (← links)
• Role of Ca(2+)-calmodulin dependent phospholamban phosphorylation on the relaxant effect of beta-adrenergic agonists (Q72585001) (← links)
• Two phosphatase sites on the Ca2+ channel affecting different kinetic functions (Q72774616) (← links)
• Quantification of the cAMP Response Element Binding Protein in Ventricular Nuclear Protein from Failing and Nonfailing Human Hearts (Q73551226) (← links)
• Protein dephosphorylation rates in myocytes after isoproterenol withdrawal (Q73755188) (← links)
• Cardiac protein phosphorylation: functional and pathophysiological correlates (Q77330780) (← links)
• Reduced inhibitor 1 and 2 activity is associated with increased protein phosphatase type 1 activity in left ventricular myocardium of one-kidney, one-clip hypertensive rats (Q81565804) (← links)